AIM: To study prospectively the psychiatric side effects of interferon-alpha in patients with hepatitis C. METHODS: Sixty-three consecutive patients at a hepatitis clinic were recruited. All were assessed using a psychiatric interview (SCID) and monitored using a self-reporting psychiatric symptom questionnaire (SCL-90). RESULTS: Patients on interferon did not suffer a drop in mood or an increase in anxiety or irritability. The subgroup with past depression also did not suffer an increase in depressive symptoms. No patients attempted suicide. CONCLUSIONS: The risk of serious psychiatric symptoms when being treated with interferon-alpha may not be high. Psychiatric illness or the possibility of psychiatric complications should not be used as a reason to refuse this treatment to patients with hepatitis C.
AIM: To study prospectively the psychiatric side effects of interferon-alpha in patients with hepatitis C. METHODS: Sixty-three consecutive patients at a hepatitis clinic were recruited. All were assessed using a psychiatric interview (SCID) and monitored using a self-reporting psychiatric symptom questionnaire (SCL-90). RESULTS:Patients on interferon did not suffer a drop in mood or an increase in anxiety or irritability. The subgroup with past depression also did not suffer an increase in depressive symptoms. No patients attempted suicide. CONCLUSIONS: The risk of serious psychiatric symptoms when being treated with interferon-alpha may not be high. Psychiatric illness or the possibility of psychiatric complications should not be used as a reason to refuse this treatment to patients with hepatitis C.
Authors: Arthur R Van Gool; Wim H J Kruit; Frederike K Engels; Gerrit Stoter; Marjolein Bannink; Alexander M M Eggermont Journal: Pharm World Sci Date: 2003-02
Authors: Elizabeth T Golub; Mary Latka; Holly Hagan; Jennifer R Havens; Sharon M Hudson; Farzana Kapadia; Jennifer V Campbell; Richard S Garfein; David L Thomas; Steffanie A Strathdee Journal: J Urban Health Date: 2004-06 Impact factor: 3.671
Authors: Montserrat Masip; Laura Tuneu; Neus Pagès; Xavier Torras; Adolfo Gallego; Josep Maria Guardiola; María José Faus; Maria Antònia Mangues Journal: Int J Clin Pharm Date: 2015-08-13
Authors: Susan Zickmund; Evelyn Y Ho; Masahiro Masuda; Laura Ippolito; Douglas R LaBrecque Journal: J Gen Intern Med Date: 2003-10 Impact factor: 5.128